Loading clinical trials...
Loading clinical trials...
Imbalance of gut bacteria is suspected to play a key role driving the progression of cirrhosis and there is hope manipulation of these bacteria may be beneficial. This study will determine if fecal mi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
First Affiliated Hospital of Chengdu Medical College
NCT03325855 · Fecal Microbiota Transplantation, Clostridium Difficile Infection, and more
NCT07299110 · Decompensated Cirrhosis Ethanol Related
NCT06855056 · Liver Cirrhosis, Decompensated Cirrhosis of Liver
NCT06431919 · Decompensated Cirrhosis, Cirrhotic Cardiomyopathy, and more
NCT05790356 · Arthritis, Arthritis, Rheumatoid, and more
IEC of Chengdu Medical College
Chendu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions